138 related articles for article (PubMed ID: 26959999)
1. Lack of Interactions Between an Antisense Oligonucleotide with 2'-O-(2-Methoxyethyl) Modifications and Major Drug Transporters.
Yu RZ; Warren MS; Watanabe T; Nichols B; Jahic M; Huang J; Burkey J; Geary RS; Henry SP; Wang Y
Nucleic Acid Ther; 2016 Apr; 26(2):111-7. PubMed ID: 26959999
[TBL] [Abstract][Full Text] [Related]
2. Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters.
Bleasby K; Houle R; Hafey M; Lin M; Guo J; Lu B; Sanchez RI; Fillgrove KL
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452431
[TBL] [Abstract][Full Text] [Related]
3. MDR1 and BCRP Transporter-Mediated Drug-Drug Interaction between Rilpivirine and Abacavir and Effect on Intestinal Absorption.
Reznicek J; Ceckova M; Ptackova Z; Martinec O; Tupova L; Cerveny L; Staud F
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696229
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human drug transporter activities by succinate dehydrogenase inhibitors.
Kerhoas M; Le Vée M; Carteret J; Jouan E; Tastet V; Bruyère A; Huc L; Fardel O
Chemosphere; 2024 Jun; 358():142122. PubMed ID: 38663675
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Human Drug Transporter Activities by the Pyrethroid Pesticides Allethrin and Tetramethrin.
Chedik L; Bruyere A; Le Vee M; Stieger B; Denizot C; Parmentier Y; Potin S; Fardel O
PLoS One; 2017; 12(1):e0169480. PubMed ID: 28099443
[TBL] [Abstract][Full Text] [Related]
6. Utilization of Rosuvastatin and Endogenous Biomarkers in Evaluating the Impact of Ritlecitinib on BCRP, OATP1B1, and OAT3 Transporter Activity.
Huh Y; Plotka A; Wei H; Kaplan J; Raha N; Towner J; Purohit VS; Dowty ME; Wolk R; Vourvahis M; King-Ahmad A; Mathialagan S; West MA; Lazzaro S; Ryu S; Rodrigues AD
Pharm Res; 2023 Nov; 40(11):2639-2651. PubMed ID: 37561322
[TBL] [Abstract][Full Text] [Related]
7. Xenobiotic, bile acid, and cholesterol transporters: function and regulation.
Klaassen CD; Aleksunes LM
Pharmacol Rev; 2010 Mar; 62(1):1-96. PubMed ID: 20103563
[TBL] [Abstract][Full Text] [Related]
8.
Rollison HE; Mitra P; Chanteux H; Fang Z; Liang X; Park SH; Costales C; Hanna I; Thakkar N; Vergis JM; Bow DAJ; Hillgren KM; Brumm J; Chu X; Hop CECA; Lai Y; Li CY; Mahar KM; Salphati L; Sane R; Shen H; Taskar K; Taub ME; Tohyama K; Xu C; Fenner KS
Drug Metab Dispos; 2024 May; ():. PubMed ID: 38697852
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of membrane transporters: an update on current approaches.
Sissung TM; Baum CE; Kirkland CT; Gao R; Gardner ER; Figg WD
Mol Biotechnol; 2010 Feb; 44(2):152-67. PubMed ID: 19950006
[TBL] [Abstract][Full Text] [Related]
10. Transporter Inhibition Profile for the Antivirals Tilorone, Quinacrine and Pyronaridine.
Vignaux PA; Lane TR; Puhl AC; Hau RK; Wright SH; Cherrington NJ; Ekins S
ACS Omega; 2023 Apr; 8(13):12532-12537. PubMed ID: 37033868
[TBL] [Abstract][Full Text] [Related]
11. Clinical Analysis and in Vitro Correlation of BCRP-Mediated Drug-Drug Interaction in the Gastrointestinal Tract.
Perera LMB; Okazaki K; Woo Y; Takahashi S; Zhang X; Mizoi K; Takahashi T; Ogihara T
Biol Pharm Bull; 2024; 47(4):750-757. PubMed ID: 38556260
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interactions of niclosamide in rats: Involvement of organic anion transporters 1 and 3 and organic cation transporter 2.
Kang MJ; Kim MJ; Kim A; Koo TS; Lee KR; Chae YJ
Chem Biol Interact; 2024 Feb; 390():110886. PubMed ID: 38280639
[TBL] [Abstract][Full Text] [Related]
13. The Structure and Mechanism of Drug Transporters.
Roberts AG
Methods Mol Biol; 2021; 2342():193-234. PubMed ID: 34272696
[TBL] [Abstract][Full Text] [Related]
14. Human ABC and SLC Transporters: The Culprit Responsible for Unspecific PSMA-617 Uptake?
Taş H; Bakos G; Bauder-Wüst U; Schäfer M; Remde Y; Roscher M; Benešová-Schäfer M
Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675472
[TBL] [Abstract][Full Text] [Related]
15. Compartmental models for apical efflux by P-glycoprotein--part 1: evaluation of model complexity.
Nagar S; Tucker J; Weiskircher EA; Bhoopathy S; Hidalgo IJ; Korzekwa K
Pharm Res; 2014 Feb; 31(2):347-59. PubMed ID: 24019023
[TBL] [Abstract][Full Text] [Related]
16. Effects of P-Glycoprotein on the Transport of DL0410, a Potential Multifunctional Anti-Alzheimer Agent.
Pang X; Wang L; Kang D; Zhao Y; Wu S; Liu AL; Du GH
Molecules; 2017 Jul; 22(8):. PubMed ID: 28757552
[TBL] [Abstract][Full Text] [Related]
17. Applicability of free drug hypothesis to drugs with good membrane permeability that are not efflux transporter substrates: A microdialysis study in rats.
Chen C; Zhou H; Guan C; Zhang H; Li Y; Jiang X; Dong Z; Tao Y; Du J; Wang S; Zhang T; Du N; Guo J; Wu Y; Song Z; Luan H; Wang Y; Du H; Zhang S; Li C; Chang H; Wang T
Pharmacol Res Perspect; 2020 Apr; 8(2):e00575. PubMed ID: 32266794
[TBL] [Abstract][Full Text] [Related]
18. The Use of Carboxyfluorescein Reveals the Transport Function of MCT6/SLC16A5 Associated with CD147 as a Chloride-Sensitive Organic Anion Transporter in Mammalian Cells.
Sugiyama K; Shimano H; Takahashi M; Shimura Y; Shimura A; Furuya T; Tomabechi R; Shirasaka Y; Higuchi K; Kishimoto H; Inoue K
J Pharm Sci; 2024 Apr; 113(4):1113-1120. PubMed ID: 38160712
[TBL] [Abstract][Full Text] [Related]
19. Novel (sulfated) thyroid hormone transporters in the solute carrier 22 family.
Chen Z; Peeters RP; Flach W; de Rooij LJ; Yildiz S; Teumer A; Nauck M; Sterenborg RBTM; Rutten JHW; Medici M; Edward Visser W; Meima ME
Eur Thyroid J; 2023 Aug; 12(4):. PubMed ID: 37074673
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of transport mechanisms of methotrexate in human choriocarcinoma cell lines by LC-MS/MS.
Bai M; Shen Q; Wu Y; Ma Z; Wang Y; Chen M; Liu D; Zhou L
J Pharm Biomed Anal; 2024 May; 247():116268. PubMed ID: 38823222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
